Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese Participants
Clinical trial NCT02821858 · COMPLETED
Trial details
- NCT number
- NCT02821858
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-14
- Primary completion
- 2016-09-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.